Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | Director | April 03, 2017 | April 05, 2017 |
| Acadian Asset Management Inc.AAMI · Entity 4180 | Director · 10% owner | June 12, 2026 | June 15, 2026 |
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date April 03, 2017 · Filed April 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 3,979 |
Reported balance
After 2017-04-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-04-03 · Grant · Acquired 20 · Balance 3,979 F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 4,585 |
Reported balance
After 2017-04-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-03 · Grant · Acquired 606 · Balance 4,585 F2: Grant of deferred stock units pursuant to the 2013 Plan. Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. The award includes dividend equivalent rights payable in the form of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG.
F2: Grant of deferred stock units pursuant to the 2013 Plan. Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. The award includes dividend equivalent rights payable in the form of deferred stock units.
Acadian Asset Management Inc.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,253 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 2,253 · Balance 2,253 F1: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F2: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan. F3: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc.
F2: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan.
F3: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 89,823 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 89,823 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Bausch Health Companies Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 440,962 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 10,720 · Balance 440,962 F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. |
| Common Shares, No Par ValueSEC Table I · non-derivative | IndirectBy Managed Funds | 73,255,869 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 73,255,869 F2: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.
F2: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BrightSphere Investment Group plc
Report date February 25, 2019 · Filed February 27, 2019
Section 16 reporting ended · disclosed 2019-02-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectBy Paulson & Co. Inc. | 20,000,552 |
Reported balance
After 2019-02-25 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-02-25 · Purchase · Acquired 14,790,038 · Balance 20,000,552 F1: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
F2: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:46 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 10,720 | $5.83 | $62,497.60 |
DisclosureSEC source: 0000885590-26-000115 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,962 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:11 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 12,677 | $4.93 | $62,497.61 |
DisclosureSEC source: 0000885590-26-000093 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,242 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 22:44 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | GrantRestricted Stock Units · Derivative | 2,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-043346 · wk-form4_1781563460.xml · derivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,253 Underlying: Common Stock · 2,253 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F2 · shares: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan. F3 · derivative.exercise_date: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc. F3 · derivative.expiration_date: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc. Read SEC document |
| May 26, 2026 Filed May 28, 2026 21:07 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 15,842 | $15.78 | $249,986.76 |
DisclosureSEC source: 0001860742-26-000079 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,823 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. Read SEC document |
| May 22, 2026 Filed May 26, 2026 22:57 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 45,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000080 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,565 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:09 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | Exercise / conversionRestricted Stock Units · Derivative | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035924 · wk-form4_1779134987.xml · derivative · entry 2 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F2 · derivative.exercise_date: On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc. F2 · derivative.expiration_date: On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:09 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | Exercise / conversionCommon Stock | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035924 · wk-form4_1779134987.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2026 Filed May 1, 2026 20:15 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,375 | $15.90 | $21,862.50 |
DisclosureSEC source: 0001860742-26-000065 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,981 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 22:20 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 11,574 | $5.40 | $62,499.60 |
DisclosureSEC source: 0000885590-26-000045 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,694 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 21:09 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,239 | $17.65 | $21,868.35 |
DisclosureSEC source: 0001860742-26-000016 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,606 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 8,992 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000003 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,120 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:23 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,402 | $15.60 | $21,871.20 |
DisclosureSEC source: 0001860742-25-000027 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,367 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:18 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 9,689 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-25-000039 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,128 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 01:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 34,721,118 | $9.00 | $312,490,062.00 |
DisclosureSEC source: 0001013594-25-001065 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 70,755,869 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| August 13, 2025 Filed Aug 13, 2025 22:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 86,409 | $7.06 | $610,047.54 |
DisclosureSEC source: 0001013594-25-001002 · form4.xml · nonDerivative · entry 3 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 36,034,751 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 22:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 1,156,640 | $6.88 | $7,957,683.20 |
DisclosureSEC source: 0001013594-25-001002 · form4.xml · nonDerivative · entry 2 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 35,948,342 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 22:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 2,000,000 | $6.35 | $12,700,000.00 |
DisclosureSEC source: 0001013594-25-001002 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 34,791,702 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:50 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 9,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018689 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,439 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:44 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 3,564,059 | $5.94 | $21,170,510.46 |
DisclosureSEC source: 0001013594-25-000764 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 32,791,702 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 00:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 1,005,376 | $5.47 | $5,499,406.72 |
DisclosureSEC source: 0001013594-25-000742 · form4.xml · nonDerivative · entry 3 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 29,227,643 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 00:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 1,029,098 | $5.24 | $5,392,473.52 |
DisclosureSEC source: 0001013594-25-000742 · form4.xml · nonDerivative · entry 2 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 28,222,267 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| June 10, 2025 Filed Jun 13, 2025 00:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 754,134 | $5.05 | $3,808,376.70 |
DisclosureSEC source: 0001013594-25-000742 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Managed Funds Disclosed balance after: 27,193,169 F1 · ownership.direct: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 27, 2025 Filed May 28, 2025 20:08 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 20,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015804 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,965 F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:28 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 54,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015022 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,055 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 14, 2025 Filed May 15, 2025 21:53 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | GrantRestricted Stock Units · Derivative | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-25-000041 · wk-form4_1747346025.xml · derivative · entry 3 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 Underlying: Common Stock · 5,750 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F3 · shares: Consists of restricted stock units issued under the Acadian Asset Management Inc. Non-Employee Directors' Equity Incentive Plan. F4 · derivative.exercise_date: On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc. F4 · derivative.expiration_date: On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:53 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | Exercise / conversionRestricted Stock Units · Derivative | 7,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-25-000041 · wk-form4_1747346025.xml · derivative · entry 2 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,764 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F2 · derivative.exercise_date: On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of Acadian Asset Management Inc., which was held on May 13, 2025. F2 · derivative.expiration_date: On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of Acadian Asset Management Inc., which was held on May 13, 2025. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:53 UTC | Acadian Asset Management Inc. AAMI · Entity 4180 | Exercise / conversionCommon Stock | 7,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-25-000041 · wk-form4_1747346025.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:00 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,887 | $11.59 | $21,870.33 |
DisclosureSEC source: 0001127602-25-013331 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,627 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 20:34 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 9,659 | $6.47 | $62,493.73 |
DisclosureSEC source: 0001127602-25-010795 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,708 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 12:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,754 | $8.06 | $62,497.24 |
DisclosureSEC source: 0001127602-25-000002 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,049 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:15 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,659 | $8.16 | $62,497.44 |
DisclosureSEC source: 0001127602-24-024684 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,295 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 23:12 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,134 | $19.29 | $21,874.86 |
DisclosureSEC source: 0001127602-24-024769 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,874 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 22:04 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 14,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-021758 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,740 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 20:45 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 8,967 | $6.97 | $62,499.99 |
DisclosureSEC source: 0001127602-24-019572 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,636 F1 · shares: Reflects Restricted Share Units issued?in?lieu?of?cash?compensation?in?connection with the Reporting Person's service on the Issuer's Board?of?Directors for the quarter ending June 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:36 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,506 | $14.52 | $21,867.12 |
DisclosureSEC source: 0001127602-24-019938 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,044 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 21:09 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | GrantRestricted Stock Units · Derivative | 7,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-24-000030 · wk-form4_1718053745.xml · derivative · entry 3 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,764 Underlying: Common Stock · 7,764 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F3 · derivative.exercise_date: On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of BrightSphere Investment Group Inc. F3 · derivative.expiration_date: On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of BrightSphere Investment Group Inc. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 21:09 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionRestricted Stock Units · Derivative | 7,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-24-000030 · wk-form4_1718053745.xml · derivative · entry 2 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · derivative.exercise_date: On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 6, 2024. F2 · derivative.expiration_date: On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 6, 2024. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 21:09 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionCommon Stock | 7,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-24-000030 · wk-form4_1718053745.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2024 Filed May 20, 2024 21:59 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 35,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016035 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,669 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 29, 2024 Filed Apr 1, 2024 20:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,890 | $10.61 | $62,492.90 |
DisclosureSEC source: 0001127602-24-011596 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,309 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:07 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,264 | $17.30 | $21,867.20 |
DisclosureSEC source: 0001127602-24-011816 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,538 F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,793 | $8.02 | $62,499.86 |
DisclosureSEC source: 0001127602-24-000125 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,419 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:42 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,282 | $17.06 | $21,870.92 |
DisclosureSEC source: 0001127602-24-000487 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,274 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:27 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,603 | $8.22 | $62,496.66 |
DisclosureSEC source: 0001127602-23-025004 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,626 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:16 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,290 | $16.95 | $21,865.50 |
DisclosureSEC source: 0001127602-23-025314 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,992 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,812 | $8.00 | $62,496.00 |
DisclosureSEC source: 0001127602-23-019997 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,023 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:11 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,089 | $20.07 | $21,856.23 |
DisclosureSEC source: 0001127602-23-020012 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,702 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 22:18 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | GrantRestricted Stock Units · Derivative | 7,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-23-000043 · wk-form4_1686349077.xml · derivative · entry 3 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,662 Underlying: Common Stock · 7,662 shares Expires not disclosed F2 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F3 · derivative.exercise_date: On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc. F3 · derivative.expiration_date: On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 22:18 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionRestricted Stock Units · Derivative | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-23-000043 · wk-form4_1686349077.xml · derivative · entry 2 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_date: On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023. F1 · derivative.expiration_date: On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 22:18 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | Exercise / conversionCommon Stock | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-23-000043 · wk-form4_1686349077.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.